Ghulam Qasam M, Goetze Jens P, Eldrup Nikolaj, Eiberg Jonas P
Department of Vascular Surgery, Rigshospitalet, Copenhagen, Denmark.
Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Denmark.
EJVES Vasc Forum. 2024 Jul 31;62:41-45. doi: 10.1016/j.ejvsvf.2024.07.040. eCollection 2024.
Abdominal aortic aneurysms (AAAs) with intraluminal thrombus (ILT) are suggested to be more prone to rupture than AAAs without. Prior studies indicate that the von Willebrand factor (vWf) plays a role in the formation of ILT since a positive correlation between ILT volume and vWf has been shown. vWf mediates the tethering of platelets at sites of endothelial injury, and the protease ADAMTS-13 cleaves larger forms of vWf, thus counteracting the thrombosis cascade and maintaining haemostatic balance. When investigating the largest quantifiable thrombus in the human body, it was hypothesised that circulating ADAMTS-13 activity may be associated with ILT size in patients with AAA and the aim was to explore this potential relationship using 3D contrast enhanced ultrasound (3D-CEUS) for ILT volume determination.
In this retrospective, exploratory study, 60 patients with AAA were evaluated, and the association between ILT volume and thickness and ADAMTS-13 was estimated using 3D-CEUS. ADAMTS-13 activity was measured in plasma samples obtained the same day. No association between ILT volume ( = -0.03, = 0.84) or ILT thickness ( = 0.02, = 0.87) and ADAMTS-13 activity was found. Likewise, when subdividing the group into lowest and highest 50% of ADAMTS-13 activity, the half with the lowest ADAMTS-13 activity (mean ILT volume ±standard deviation [SD]: 32 ± 34 mL) did not differ from the half with the highest ADAMTS-13 activity (43 ± 24 mL) when comparing ILT volume ( = 0.172, = 2.95) and thickness ( = 0.070).
After evaluating the largest quantifiable intraluminal thrombus in the vasculature, it was concluded that, surprisingly, circulating ADAMTS-13 activity seems unrelated to ILT formation in AAA.
有腔内血栓(ILT)的腹主动脉瘤(AAA)被认为比无腔内血栓的腹主动脉瘤更容易破裂。先前的研究表明,血管性血友病因子(vWf)在ILT的形成中起作用,因为已显示ILT体积与vWf之间存在正相关。vWf在内皮损伤部位介导血小板的黏附,而蛋白酶ADAMTS-13裂解较大形式的vWf,从而抵消血栓形成级联反应并维持止血平衡。在研究人体中最大可量化血栓时,有人提出循环中的ADAMTS-13活性可能与AAA患者的ILT大小有关,目的是使用三维对比增强超声(3D-CEUS)测定ILT体积来探索这种潜在关系。
在这项回顾性探索性研究中,对60例AAA患者进行了评估,并使用3D-CEUS评估了ILT体积、厚度与ADAMTS-13之间的关联。在同一天采集的血浆样本中测量ADAMTS-13活性。未发现ILT体积(r = -0.03,P = 0.84)或ILT厚度(r = 0.02,P = 0.87)与ADAMTS-13活性之间存在关联。同样,当将该组分为ADAMTS-13活性最低和最高的50%时,比较ILT体积(r = 0.172,P = 2.95)和厚度(r = 0.070)时,ADAMTS-13活性最低的一半(平均ILT体积±标准差[SD]:32±34 mL)与ADAMTS-13活性最高的一半(43±24 mL)没有差异。
在评估了脉管系统中最大可量化的腔内血栓后,得出的结论是,令人惊讶的是,循环中的ADAMTS-13活性似乎与AAA中ILT的形成无关。